Calcium gluconate is a mineral supplement and medication. As a medication it is used by injection into a vein to treat low blood calcium, high blood potassium, and magnesium toxicity. Supplementation is generally only required when there is not enough calcium in the diet. Supplementation may be done to treat or prevent osteoporosis or rickets. It can also be taken by mouth but is not recommended for injection into a muscle.
This report contains market size and forecasts of Calcium Gluconate for Intravenous Injection in global, including the following market information:
- Global Calcium Gluconate for Intravenous Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Calcium Gluconate for Intravenous Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Calcium Gluconate for Intravenous Injection companies in 2022 (%)
The global Calcium Gluconate for Intravenous Injection market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Static Push Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Calcium Gluconate for Intravenous Injection include hameln pharma, Renan, Xinganjiang Pharma, Ruibang, Xinhong, Global Calcium and Tomita Pharma, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Calcium Gluconate for Intravenous Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Calcium Gluconate for Intravenous Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Calcium Gluconate for Intravenous Injection Market Segment Percentages, by Type, 2022 (%)
Global Calcium Gluconate for Intravenous Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Calcium Gluconate for Intravenous Injection Market Segment Percentages, by Application, 2022 (%)
Global Calcium Gluconate for Intravenous Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Calcium Gluconate for Intravenous Injection Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Calcium Gluconate for Intravenous Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Calcium Gluconate for Intravenous Injection revenues share in global market, 2022 (%)
- Key companies Calcium Gluconate for Intravenous Injection sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Calcium Gluconate for Intravenous Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- hameln pharma
- Renan
- Xinganjiang Pharma
- Ruibang
- Xinhong
- Global Calcium
- Tomita Pharma
